Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: lamberts ...

I think by late 2010, the $100M to PDS in licensing may be achievable if things go well. Maybe even surpassed and significantly if things go very well in litigation and licensing loosens up. Hopefully a T3 settlement will kickstart that flow, but until it does start flowing, it it hard to guage, IMO.

However, what I was referring to is more about what I think Baroni's involvement means and how I think that might alter the make up of PTSC / PDSG.

Share
New Message
Please login to post a reply